Therapeutic efficacy and bone mineral density response during and following a three-month re-treatment of endometriosis with nafarelin (Synarel)

G. David Adamson, G D Adamson, W L Heinrichs, Milan R. Henzl, M R Henzl, A A Yuzpe, Albert Yuzpe, Christer Bergquist, C Bergquist, J J Jacobson, Jan J. Jacobson, S Eriksson, Staffan Eriksson, Long Kwei, L Kwei, Sandra M. Gilbert, S M Gilbert
American Journal of Obstetrics and Gynecology · 1997 · vol. 177(6) , pp. 1413–1418 · doi:10.1016/s0002-9378(97)70084-x · PMID:9423744 · W2146137592
article OA: closed CC0 ⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Bone Density Endometriosis Endometriosis Hormones Nafarelin Adult Endometriosis Estradiol Estradiol Female Hormones Hormones Humans Menstrual Cycle Menstrual Cycle Middle Aged Nafarelin Nafarelin Recurrence Retreatment

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (15)

Cited by (8)

Source provenance

europepmc
last seen: 2026-06-20T06:14:18.781669+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:46.468712+00:00
unpaywall
last seen: 2026-06-20T06:35:16.286784+00:00
License: CC0 · commercial use OK